Neonatal Seizure Registry - Developmental Functional EValuation (NSR-DEV)

August 8, 2023 updated by: University of California, San Francisco
The NSR-DEV study is a longitudinal cohort study of around 280 Neonatal Seizure Registry participants that aims to evaluate childhood outcomes after acute symptomatic neonatal seizures, as well as examine risk factors for developmental disabilities and whether these are modified by parent well-being.

Study Overview

Detailed Description

Neonatal seizures due to brain injury (acute symptomatic seizures) are associated with high risk of neurodevelopmental disability in infancy. Although prognosis in early childhood is a critical question for parents and providers, outcomes beyond infancy are largely unknown. Further, parents of infants with neonatal seizures are at risk for mental health disorders, which can undermine their ability to care for a child with medical complexity and may contribute to impaired child development.

The NSR-DEV study is a longitudinal cohort study of around 280 Neonatal Seizure Registry participants enrolled at one of nine sites across the USA. Participants will be evaluated using developmental questionnaires and in-person neurodevelopmental testing. Parent well-being will be assessed at each time point.

Study Type

Observational

Enrollment (Estimated)

280

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • California
      • San Francisco, California, United States, 94158
        • Recruiting
        • University of California, San Francisco
        • Contact:
        • Principal Investigator:
          • Hannah C. Glass, MDCM, MAS
        • Sub-Investigator:
          • Charles McCulloch, PhD
        • Sub-Investigator:
          • Elizabeth E. Rogers, MD
        • Sub-Investigator:
          • Linda S. Franck, PhD, RN, FAAN
        • Sub-Investigator:
          • Yi Li, MD
      • Stanford, California, United States, 94304
        • Recruiting
        • Stanford University
        • Contact:
        • Principal Investigator:
          • Courtney J. Wusthoff, MD
    • District of Columbia
      • Washington, District of Columbia, United States, 20010
        • Recruiting
        • Children's National Medical Center
        • Contact:
        • Principal Investigator:
          • Tayyba Anwar, MD
    • Massachusetts
      • Boston, Massachusetts, United States, 02115
      • Boston, Massachusetts, United States, 02114
        • Recruiting
        • Massachusetts General Hospital
        • Contact:
        • Principal Investigator:
          • Catherine Chu, MD
    • Michigan
      • Ann Arbor, Michigan, United States, 48109
        • Recruiting
        • University of Michigan
        • Principal Investigator:
          • Renee A. Shellhaas, MD, MS
        • Contact:
        • Principal Investigator:
          • Giulia Benedetti, MD
    • North Carolina
      • Durham, North Carolina, United States, 27705
        • Recruiting
        • Duke University
        • Principal Investigator:
          • Monica E. Lemmon, MD
        • Contact:
    • Ohio
      • Cincinnati, Ohio, United States, 45229
        • Recruiting
        • Cincinnati Children's Hospital Medical Center
        • Contact:
        • Principal Investigator:
          • Cameron Thomas, MD, MS
    • Pennsylvania
      • Philadelphia, Pennsylvania, United States, 19104
        • Recruiting
        • Children's Hospital of Philadelphia
        • Contact:
        • Principal Investigator:
          • Nicholas Abend, MD, MSCE

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

2 years to 8 years (Child)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Outpatient, family members/caregivers, providers, children/minors, subjects unable to read, speak or understand English

Description

Inclusion Criteria:

  • Enrolled in NSR-II
  • Alive at the start of the NSR-DEV study period
  • Parent(s) who are English or Spanish literate (with assistance of interpreter)

Exclusion Criteria:

  • Neonates who were found to have exclusion criteria after NSR-II enrollment
  • Risk for adverse outcome independent of seizures and underlying brain injury (including but not limited to: inborn errors of metabolism, fetal infection, brain malformation)
  • Transient cause for seizures (e.g., mild hypoglycemia, hyponatremia, hypocalcemia with normal neuroimaging)
  • Neonatal-onset epilepsy syndromes

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Full scale IQ (FSIQ) score for each child on the Wechsler Preschool and Primary Scale of Intelligence, 4th Edition (WPPSI-IV)
Time Frame: At age 5.5 years during in-person study visit
The WPPSI-IV is an in-person assessment administered by a psychologist or psychometrician that will be used to measure neurocognitive ability. Full Scale IQ (FSIQ) will be generated for each participant from the following subtests: Verbal Comprehension Index (VCI), Visual Spatial Index (VSI), Fluid Reasoning Index (FRI), Working Memory Index (WMI), Processing Speed Index (PSI), Receptive Vocabulary and Picture Naming.
At age 5.5 years during in-person study visit

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in scores over time for each child on the Vineland Adaptive Behavior Scales, 3rd Edition
Time Frame: At enrollment study visit and annual visits when the child is age 3, 4, 5.5, 7, and 8
The Vineland Adaptive Behavior Scales Parent Form measures adaptive behavior and intellectual and developmental function. Adaptive behavior is predictive of functional performance in school and is linked to both cognitive and executive function. Scores for each participant at each timepoint are generated based on parent reports in the following categories: Communication, Daily Living Skills, Socialization, Motor Skills, Adaptive Behavior Composite (ABC). We will look at the change in score over time for each participant during the study period after the Vineland-3 is administered at each timepoint.
At enrollment study visit and annual visits when the child is age 3, 4, 5.5, 7, and 8

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Scores for each child on Behavior Rating Inventory of Executive Function®, Preschool version (BRIEF-P)
Time Frame: At enrollment study visit
BRIEF-P is a standardized measure of early childhood executive function. Scores are generated based on parent report of a child's function in the Global Executive Composite (GBC) scale.
At enrollment study visit
Scores for each child on Behavior Rating Inventory of Executive Function®, Preschool version (BRIEF-P)
Time Frame: At age 5.5 years during in-person study visit
BRIEF-P is a standardized measure of early childhood executive function. Scores are generated based on parent report of a child's function in the Global Executive Composite (GBC) scale.
At age 5.5 years during in-person study visit
Scores for each child on The Social Responsiveness Scale, 2nd edition (SRS-2) - Parent Form
Time Frame: At enrollment study visit
SRS-2 (Parent Form) is an online tool to identify social impairment associated with Autism Spectrum Disorders and quantifies Autism Spectrum Disorder severity. Scores are generated based on parent report of child's function in these scales: Social Awareness, Social Cognition, Social Communication, Social Motivation, Restricted Behaviors and Repetitive Behavior. A total score as well as separate scale scores are generated.
At enrollment study visit
Scores for each child on The Social Responsiveness Scale, 2nd edition (SRS-2) - Parent Form
Time Frame: At age 5.5 years during in-person study visit
SRS-2 (Parent Form) is an online tool to identify social impairment associated with Autism Spectrum Disorders and quantifies Autism Spectrum Disorder severity. Scores are generated based on parent report of child's function in these scales: Social Awareness, Social Cognition, Social Communication, Social Motivation, Restricted Behaviors and Repetitive Behavior. A total score as well as separate scale scores are generated.
At age 5.5 years during in-person study visit
Scores for each child on The Social Responsiveness Scale, 2nd edition (SRS-2) - Teacher Form
Time Frame: At age 5.5 years during in-person study visit
SRS-2 (Teacher Form) is an online tool to identify social impairment associated with Autism Spectrum Disorders and quantifies Autism Spectrum Disorder severity. Scores are generated based on teacher report of child's function in these scales: Social Awareness, Social Cognition, Social Communication, Social Motivation, Restricted Behaviors and Repetitive Behavior. A total score as well as separate scale scores are generated.
At age 5.5 years during in-person study visit
Scores for each child on Behavior Assessment System for Children, 3rd edition (BASC-3) - Parent Form
Time Frame: At enrollment study visit
BASC-3 (Parent Form) is a measure of both adaptive and problem behaviors. Scores are generated based on parent report of a child's behavior in these scales: Externalizing Problems, Internalizing Problems, Adaptive Skills, Hyperactivity, Attention Problems, Atypicality, and Social Skills.
At enrollment study visit
Scores for each child on Behavior Assessment System for Children, 3rd edition (BASC-3) - Parent Form
Time Frame: At age 5.5 years during in-person study visit
BASC-3 (Parent Form) is a measure of both adaptive and problem behaviors. Scores are generated based on parent report of a child's behavior in these scales: Externalizing Problems, Internalizing Problems, Adaptive Skills, Hyperactivity, Attention Problems, Atypicality, and Social Skills.
At age 5.5 years during in-person study visit
Scores for each child on Behavior Assessment System for Children, 3rd edition (BASC-3) - Teacher Form
Time Frame: At age 5.5 years during in-person study visit
BASC-3 (Teacher Form) is a measure of both adaptive and problem behaviors. Scores are generated based on teacher report of a child's behavior in these scales: Externalizing Problems, Internalizing Problems, Behavior Symptoms Index, Adaptive Skills, School Problems, Hyperactivity, Attention Problems, Atypicality, and Social Skills.
At age 5.5 years during in-person study visit
Scores for each child on Child Sensory Profile, 2nd edition - Parent Form
Time Frame: At enrollment study visit
Child Sensory Profile, 2nd edition (Parent Form) is a standardized instrument to evaluate sensory processing issues, including oversensitivity to sights, sounds, textures, and other sensory input. Scores are generated based on parent report of child's processing in these areas: Seeking/Seeker, Avoiding/Avoider, Sensitivity/Sensor, Registration/Bystander, Auditory Processing, Visual Processing, Touch Processing, Movement Processing, Body Position Processing, and Oral Sensory Processing.
At enrollment study visit
Scores for each child on Child Sensory Profile, 2nd edition - Parent Form
Time Frame: At age 5.5 years during in-person study visit
Child Sensory Profile, 2nd edition (Parent Form) is a standardized instrument to evaluate sensory processing issues, including oversensitivity to sights, sounds, textures, and other sensory input. Scores are generated based on parent report of child's processing in these areas: Seeking/Seeker, Avoiding/Avoider, Sensitivity/Sensor, Registration/Bystander, Auditory Processing, Visual Processing, Touch Processing, Movement Processing, Body Position Processing, and Oral Sensory Processing.
At age 5.5 years during in-person study visit
Scores for each child on Kaufman Test of Educational Achievement, 3rd edition (KTEA-3)
Time Frame: At age 5.5 years during in-person study visit
KTEA-3 is a standardized instrument that provides in-depth assessment and evaluation of key academic skills. Scores are generated based on child performance in these areas: Spelling, Letter and Word Recognition and Math Computation.
At age 5.5 years during in-person study visit
Scores for each parent/guardian on Hospital Anxiety Depression Scale (HADS)
Time Frame: At enrollment study visit
Hospital Anxiety Depression Scale (HADS) is a well-validated, 14-item, measure of symptoms of anxiety and depression. Scores will be generated based on parent/guardian response to the HADS questionnaire.
At enrollment study visit
Scores for each parent/guardian on Hospital Anxiety Depression Scale (HADS)
Time Frame: At (child) age 3 years during annual study visit
Hospital Anxiety Depression Scale (HADS) is a well-validated, 14-item, measure of symptoms of anxiety and depression. Scores will be generated based on parent/guardian response to the HADS questionnaire.
At (child) age 3 years during annual study visit
Scores for each parent/guardian on Hospital Anxiety Depression Scale (HADS)
Time Frame: At (child) age 4 years during annual study visit
Hospital Anxiety Depression Scale (HADS) is a well-validated, 14-item, measure of symptoms of anxiety and depression. Scores will be generated based on parent/guardian response to the HADS questionnaire.
At (child) age 4 years during annual study visit
Scores for each parent/guardian on Hospital Anxiety Depression Scale (HADS)
Time Frame: At (child) age 5.5 years during in-person study visit
Hospital Anxiety Depression Scale (HADS) is a well-validated, 14-item, measure of symptoms of anxiety and depression. Scores will be generated based on parent/guardian response to the HADS questionnaire.
At (child) age 5.5 years during in-person study visit
Scores for each parent/guardian on Hospital Anxiety Depression Scale (HADS)
Time Frame: At (child) age 7 years during annual study visit
Hospital Anxiety Depression Scale (HADS) is a well-validated, 14-item, measure of symptoms of anxiety and depression. Scores will be generated based on parent/guardian response to the HADS questionnaire.
At (child) age 7 years during annual study visit
Scores for each parent/guardian on Hospital Anxiety Depression Scale (HADS)
Time Frame: At (child) age 8 years during annual study visit
Hospital Anxiety Depression Scale (HADS) is a well-validated, 14-item, measure of symptoms of anxiety and depression. Scores will be generated based on parent/guardian response to the HADS questionnaire.
At (child) age 8 years during annual study visit
Scores for each parent/guardian on WHO Quality of Life-BREF (WHOQOL-BREF)
Time Frame: At enrollment study visit
WHO Quality of Life-BREF (WHOQOL-BREF) assesses four domains of health: physical, psychological, social relationships, and environment. It also includes two general questions on self-perceived QOL and general health. Scores will be generated based on parent/guardian response to the WHOQOL-BREF questionnaire.
At enrollment study visit
Scores for each parent/guardian on WHO Quality of Life-BREF (WHOQOL-BREF)
Time Frame: At (child) age 3 years during annual study visit
WHO Quality of Life-BREF (WHOQOL-BREF) assesses four domains of health: physical, psychological, social relationships, and environment. It also includes two general questions on self-perceived QOL and general health. Scores will be generated based on parent/guardian response to the WHOQOL-BREF questionnaire.
At (child) age 3 years during annual study visit
Scores for each parent/guardian on WHO Quality of Life-BREF (WHOQOL-BREF)
Time Frame: At (child) age 4 years during annual study visit
WHO Quality of Life-BREF (WHOQOL-BREF) assesses four domains of health: physical, psychological, social relationships, and environment. It also includes two general questions on self-perceived QOL and general health. Scores will be generated based on parent/guardian response to the WHOQOL-BREF questionnaire.
At (child) age 4 years during annual study visit
Scores for each parent/guardian on WHO Quality of Life-BREF (WHOQOL-BREF)
Time Frame: At (child) age 5.5 years during in-person study visit
WHO Quality of Life-BREF (WHOQOL-BREF) assesses four domains of health: physical, psychological, social relationships, and environment. It also includes two general questions on self-perceived QOL and general health. Scores will be generated based on parent/guardian response to the WHOQOL-BREF questionnaire.
At (child) age 5.5 years during in-person study visit
Scores for each parent/guardian on WHO Quality of Life-BREF (WHOQOL-BREF)
Time Frame: At (child) age 7 years during annual study visit
WHO Quality of Life-BREF (WHOQOL-BREF) assesses four domains of health: physical, psychological, social relationships, and environment. It also includes two general questions on self-perceived QOL and general health. Scores will be generated based on parent/guardian response to the WHOQOL-BREF questionnaire.
At (child) age 7 years during annual study visit
Scores for each parent/guardian on WHO Quality of Life-BREF (WHOQOL-BREF)
Time Frame: At (child) age 8 years during annual study visit
WHO Quality of Life-BREF (WHOQOL-BREF) assesses four domains of health: physical, psychological, social relationships, and environment. It also includes two general questions on self-perceived QOL and general health. Scores will be generated based on parent/guardian response to the WHOQOL-BREF questionnaire.
At (child) age 8 years during annual study visit
Scores for each parent/guardian on The Impact on Family Scale (IOF)
Time Frame: At enrollment study visit
The Impact on Family Scale (IOF) measures parent perception of the ill child's impact on the family. The score represents a construct of personal, family and social impact. Scores will be generated based on parent/guardian response to the IOF questionnaire.
At enrollment study visit
Scores for each parent/guardian on The Impact on Family Scale (IOF)
Time Frame: At (child) age 3 years during annual study visit
The Impact on Family Scale (IOF) measures parent perception of the ill child's impact on the family. The score represents a construct of personal, family and social impact. Scores will be generated based on parent/guardian response to the IOF questionnaire.
At (child) age 3 years during annual study visit
Scores for each parent/guardian on The Impact on Family Scale (IOF)
Time Frame: At (child) age 4 years during annual study visit
The Impact on Family Scale (IOF) measures parent perception of the ill child's impact on the family. The score represents a construct of personal, family and social impact. Scores will be generated based on parent/guardian response to the IOF questionnaire.
At (child) age 4 years during annual study visit
Scores for each parent/guardian on The Impact on Family Scale (IOF)
Time Frame: At (child) age 5.5 years during in-person study visit
The Impact on Family Scale (IOF) measures parent perception of the ill child's impact on the family. The score represents a construct of personal, family and social impact. Scores will be generated based on parent/guardian response to the IOF questionnaire.
At (child) age 5.5 years during in-person study visit
Scores for each parent/guardian on The Impact on Family Scale (IOF)
Time Frame: At (child) age 7 years during annual study visit
The Impact on Family Scale (IOF) measures parent perception of the ill child's impact on the family. The score represents a construct of personal, family and social impact. Scores will be generated based on parent/guardian response to the IOF questionnaire.
At (child) age 7 years during annual study visit
Scores for each parent/guardian on The Impact on Family Scale (IOF)
Time Frame: At (child) age 8 years during annual study visit
The Impact on Family Scale (IOF) measures parent perception of the ill child's impact on the family. The score represents a construct of personal, family and social impact. Scores will be generated based on parent/guardian response to the IOF questionnaire.
At (child) age 8 years during annual study visit
Scores for each parent/guardian on The Impact of Events Scale - Revised
Time Frame: At enrollment study visit
The Impact of Events Scale - Revised is a validated measure of post-traumatic stress reactions. Scores will be generated based on parent/guardian response to the Impact of Events Scale - Revised questionnaire.
At enrollment study visit
Scores for each parent/guardian on The Impact of Events Scale - Revised
Time Frame: At (child) age 3 years during annual study visit
The Impact of Events Scale - Revised is a validated measure of post-traumatic stress reactions. Scores will be generated based on parent/guardian response to the Impact of Events Scale - Revised questionnaire.
At (child) age 3 years during annual study visit
Scores for each parent/guardian on The Impact of Events Scale - Revised
Time Frame: At (child) age 4 years during annual study visit
The Impact of Events Scale - Revised is a validated measure of post-traumatic stress reactions. Scores will be generated based on parent/guardian response to the Impact of Events Scale - Revised questionnaire.
At (child) age 4 years during annual study visit
Scores for each parent/guardian on The Impact of Events Scale - Revised
Time Frame: At (child) age 5.5 years during in-person study visit
The Impact of Events Scale - Revised is a validated measure of post-traumatic stress reactions. Scores will be generated based on parent/guardian response to the Impact of Events Scale - Revised questionnaire.
At (child) age 5.5 years during in-person study visit
Scores for each parent/guardian on The Impact of Events Scale - Revised
Time Frame: At (child) age 7 years during annual study visit
The Impact of Events Scale - Revised is a validated measure of post-traumatic stress reactions. Scores will be generated based on parent/guardian response to the Impact of Events Scale - Revised questionnaire.
At (child) age 7 years during annual study visit
Scores for each parent/guardian on The Impact of Events Scale - Revised
Time Frame: At (child) age 8 years during annual study visit
The Impact of Events Scale - Revised is a validated measure of post-traumatic stress reactions. Scores will be generated based on parent/guardian response to the Impact of Events Scale - Revised questionnaire.
At (child) age 8 years during annual study visit
Scores for each parent/guardian on The Post Traumatic Growth Inventory
Time Frame: At enrollment study visit
The Post Traumatic Growth Inventory is a commonly used, validated measure of resilience that has been incorporated into studies of parents of sick neonates and children. Scores will be generated based on parent/guardian response to The Post Traumatic Growth Inventory questionnaire.
At enrollment study visit
Scores for each parent/guardian on The Post Traumatic Growth Inventory
Time Frame: At (child) age 3 years during annual study visit
The Post Traumatic Growth Inventory is a commonly used, validated measure of resilience that has been incorporated into studies of parents of sick neonates and children. Scores will be generated based on parent/guardian response to The Post Traumatic Growth Inventory questionnaire.
At (child) age 3 years during annual study visit
Scores for each parent/guardian on The Post Traumatic Growth Inventory
Time Frame: At (child) age 4 years during annual study visit
The Post Traumatic Growth Inventory is a commonly used, validated measure of resilience that has been incorporated into studies of parents of sick neonates and children. Scores will be generated based on parent/guardian response to The Post Traumatic Growth Inventory questionnaire.
At (child) age 4 years during annual study visit
Scores for each parent/guardian on The Post Traumatic Growth Inventory
Time Frame: At (child) age 5.5 years during in-person study visit
The Post Traumatic Growth Inventory is a commonly used, validated measure of resilience that has been incorporated into studies of parents of sick neonates and children. Scores will be generated based on parent/guardian response to The Post Traumatic Growth Inventory questionnaire.
At (child) age 5.5 years during in-person study visit
Scores for each parent/guardian on The Post Traumatic Growth Inventory
Time Frame: At (child) age 7 years during annual study visit
The Post Traumatic Growth Inventory is a commonly used, validated measure of resilience that has been incorporated into studies of parents of sick neonates and children. Scores will be generated based on parent/guardian response to The Post Traumatic Growth Inventory questionnaire.
At (child) age 7 years during annual study visit
Scores for each parent/guardian on The Post Traumatic Growth Inventory
Time Frame: At (child) age 8 years during annual study visit
The Post Traumatic Growth Inventory is a commonly used, validated measure of resilience that has been incorporated into studies of parents of sick neonates and children. Scores will be generated based on parent/guardian response to The Post Traumatic Growth Inventory questionnaire.
At (child) age 8 years during annual study visit
Written responses from each parent/guardian on Open Ended Questions
Time Frame: At enrollment study visit
The Open Ended Questions ask parents/guardians to explain different aspects of caring for their child and their child's healthcare journey and for any advice they would give to both the healthcare team and other parents of children with similar conditions.
At enrollment study visit
Written responses from each parent/guardian on Open Ended Questions
Time Frame: At (child) age 3 years during annual study visit
The Open Ended Questions ask parents/guardians to explain different aspects of caring for their child and their child's healthcare journey and for any advice they would give to both the healthcare team and other parents of children with similar conditions.
At (child) age 3 years during annual study visit
Written responses from each parent/guardian on Open Ended Questions
Time Frame: At (child) age 4 years during annual study visit
The Open Ended Questions ask parents/guardians to explain different aspects of caring for their child and their child's healthcare journey and for any advice they would give to both the healthcare team and other parents of children with similar conditions.
At (child) age 4 years during annual study visit
Written responses from each parent/guardian on Open Ended Questions
Time Frame: At (child) age 5.5 years during in-person study visit
The Open Ended Questions ask parents/guardians to explain different aspects of caring for their child and their child's healthcare journey and for any advice they would give to both the healthcare team and other parents of children with similar conditions.
At (child) age 5.5 years during in-person study visit
Written responses from each parent/guardian on Open Ended Questions
Time Frame: At (child) age 7 years during annual study visit
The Open Ended Questions ask parents/guardians to explain different aspects of caring for their child and their child's healthcare journey and for any advice they would give to both the healthcare team and other parents of children with similar conditions.
At (child) age 7 years during annual study visit
Written responses from each parent/guardian on Open Ended Questions
Time Frame: At (child) age 8 years during annual study visit
The Open Ended Questions ask parents/guardians to explain different aspects of caring for their child and their child's healthcare journey and for any advice they would give to both the healthcare team and other parents of children with similar conditions.
At (child) age 8 years during annual study visit

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 15, 2020

Primary Completion (Estimated)

February 29, 2024

Study Completion (Estimated)

February 29, 2024

Study Registration Dates

First Submitted

March 31, 2020

First Submitted That Met QC Criteria

April 3, 2020

First Posted (Actual)

April 8, 2020

Study Record Updates

Last Update Posted (Actual)

August 14, 2023

Last Update Submitted That Met QC Criteria

August 8, 2023

Last Verified

August 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

In accordance with study sponsor

IPD Sharing Time Frame

In accordance with study sponsor

IPD Sharing Access Criteria

In accordance with study sponsor

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

3
Subscribe